Ocular silicon distribution and clearance following intravitreal injection of porous silicon microparticles

Experimental Eye Research - Tập 116 - Trang 161-168 - 2013
Alejandra Nieto1,2, Huiyuan Hou1,2, Michael J. Sailor2, William R. Freeman1, Lingyun Cheng1
1Jacobs Retina Center at Shiley Eye Center at University of California, San Diego, USA
2Department of Chemistry and Biochemistry, University of California, San Diego, USA

Tài liệu tham khảo

Anglin, 2008, Porous silicon in drug delivery devices and materials, Adv. Drug Deliv. Rev., 60, 1266, 10.1016/j.addr.2008.03.017 Araie, 1991, The loss of fluorescein, fluorescein glucuronide and fluorescein isothiocyanate dextran from the vitreous by the anterior and retinal pathways, Exp. Eye Res., 52, 27, 10.1016/0014-4835(91)90125-X Becker, 1961, The turnover of bromide in the rabbit eye, Arch. Ophthalmol., 65, 837, 10.1001/archopht.1961.01840020839018 Bimbo, 2010, Biocompatibility of thermally hydrocarbonized porous silicon nanoparticles and their biodistribution in rats, ACS Nano, 4, 3023, 10.1021/nn901657w Brinker, 1990 Brunauer, 1938, Adsorption of gases in multimolecular layers, J. Am. Chem. Soc., 60, 309, 10.1021/ja01269a023 Chen, 2013, Different intravitreal properties of three triamcinolone formulations and their possible impact on retina practice, Invest. Ophthalmol. Vis. Sci., 54, 2178, 10.1167/iovs.12-11460 Cheng, 2004, Characterization of a novel intraocular drug-delivery system using crystalline lipid antiviral prodrugs of ganciclovir and cyclic cidofovir, Invest. Ophthalmol. Vis. Sci., 45, 4138, 10.1167/iovs.04-0064 Cheng, 2008, Intravitreal properties of porous silicon photonic crystals: a potential self-reporting intraocular drug-delivery vehicle, Br. J. Ophthalmol., 92, 705, 10.1136/bjo.2007.133587 Chhablani, 2013, Oxidized porous silicon particles covalently grafted with daunorubicin as a sustained intraocular drug delivery system, Invest. Ophthalmol. Vis. Sci., 54, 1268, 10.1167/iovs.12-11172 Collery, 1998 Davson, 1956, A comparative study of the total carbon dioxide in the ocular fluids, cerebrospinal fluid, and plasma of some mammalian species, J. Physiol., 132, 454, 10.1113/jphysiol.1956.sp005537 Dyck, 2000, Spectrometric determination of silicon in food and biological samples: an interlaboratory trial, J. Anal. At. Spectrom., 15, 735, 10.1039/b000572j Gregg, 1982 Hauptkorn, 2001, Determination of silicon in biological samples by ICP-OES after non-oxidative decomposition under alkaline conditions, Fresen J. Anal Chem., 370, 246, 10.1007/s002160100759 Iler, 1979 Jurkic, 2013, Biological and therapeutic effects of ortho-silicic acid and some ortho-silicic acid-releasing compounds: new perspectives for therapy, Nutr. Metab., 10, 10.1186/1743-7075-10-2 Kashanian, 2010, Evaluation of mesoporous silicon/polycaprolactone composites as ophthalmic implants, Acta Biomater., 6, 3566, 10.1016/j.actbio.2010.03.031 Kruk, 1999, Relations between pore structure parameters and their implications for characterization of MCM-41 using Gas Adsorption and X-ray diffraction, Chem. Mater., 11, 492, 10.1021/cm981006e Leoni, 2002, Characterization of nanoporous membranes for immunoisolation: diffusion properties and tissue effects, Biomed. Microdevices, 4, 131, 10.1023/A:1014639332543 Low, 2006, Evaluation of mammalian cell adhesion on surface-modified porous silicon, Biomaterials, 27, 4538, 10.1016/j.biomaterials.2006.04.015 McMaster, 1967, The rate of aqueous humor formation in buphthalmic rabbit eyes, Invest. Ophthalmol., 6, 84 Mertz, 1981, The essential trace-Elements, Science, 213, 1332, 10.1126/science.7022654 Moseley, 1984, Routes of clearance of radioactive water from the rabbit vitreous, Brit. J. Ophthalmol., 68, 145, 10.1136/bjo.68.3.145 Nan, 2010, Characterisation of systemic and ocular drug level of triamcinolone acetonide following a single sub-tenon injection, Brit. J. Ophthalmol., 94, 654, 10.1136/bjo.2009.172106 Park, 2009, Biodegradable luminescent porous silicon nanoparticles for in vivo applications, Nat. Mater., 8, 331, 10.1038/nmat2398 Roberts, 1990, Silicon measurement in serum and urine by direct current plasma emission spectrometry, Clin. Chem., 36, 1460, 10.1093/clinchem/36.8.1460 Salonen, 2008, Mesoporous silicon in drug delivery applications, J. Pharm. Sci-US, 97, 632, 10.1002/jps.20999 Thonissen, 1997, Multilayer structures of porous silicon Veilleux-Lemieux, 2012, Effects of endotoxemia on the pharmacodynamics and pharmacokinetics of ketamine and xylazine anesthesia in Sprague–Dawley rats, Vet. Med. Res. Rep., 3, 99 Vincent, 1994, Optical-properties of porous silicon superlattices, Appl. Phys. Lett., 64, 2367, 10.1063/1.111982 Wills, 2008, Copper and zinc distribution in the human retina: relationship to cadmium accumulation, age, and gender, Exp. Eye Res., 87, 80, 10.1016/j.exer.2008.04.013 Wu, 2011, Real-time monitoring of sustained drug release using the optical properties of porous silicon photonic crystal particles, Biomaterials, 32, 1957, 10.1016/j.biomaterials.2010.11.013